Meanwhile, thalidomide is a TNFα inhibitor that down-regulating the NFκB-iNOS pathway29, which simultaneously contributes to HPS and muscle wasting in cirrhosis. The gene discussed is NOS2; the disease is Hermansky-Pudlak syndrome.